Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis
Public ClinicalTrials.gov record NCT04741087. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Combined Phase 2/3 12-week, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy of AMT-101 in Subjects With Chronic Antibiotic-resistant Pouchitis
Study identification
- NCT ID
- NCT04741087
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Applied Molecular Transport
- Industry
- Enrollment
- 22 participants
Conditions and interventions
Conditions
Interventions
- AMT-101 (oral)-Dose A Drug
- AMT-101 (oral)-Dose B Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 4, 2021
- Primary completion
- Mar 10, 2022
- Completion
- Apr 21, 2022
- Last update posted
- Sep 13, 2022
2021 – 2022
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connecticut Clinical Research Institute | Bristol | Connecticut | 06010 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Gastrointestinal Associates - Jackson | Flowood | Mississippi | 39232 | — |
| University of North Carolina GI | Chapel Hill | North Carolina | 27514 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Gastrointestinal Asssociates- GIA Clinical Trials, LLC | Knoxville | Tennessee | 37909 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| Tyler Research Institute, LLC | Tyler | Texas | 75701 | — |
| University of Utah Health Sciences Center | Salt Lake City | Utah | 84132 | — |
| Washington Gastroenterology, Tacoma | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04741087, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04741087 live on ClinicalTrials.gov.